MUMBAI / NEW DELHI, SEPTEMBER 16, 2026 — During trading on Wednesday, September 16, 2026, market participants closely tracked the unfolding primary market landscape following the launch of Injecto Polymers’ ₹56-crore SME public issue on Friday, September 11, 2026. According to tracking data reported by Chittorgarh and IPOWatch, along with regulatory filings accessed on Moneycontrol, the small and medium enterprise offering has drawn considerable retail and HNI attention amid a broader wave of primary market activity.
Injecto Polymers IPO
NSE: BEPL
▼ ₹0.69 (-0.57%)
Day Range: ₹118.32 – ₹123.02
52W Range: ₹74.20 – ₹138.50
● Real-Time Feed
Injecto Polymers SME IPO: Key Issue Parameters & Timeline
As verified via filings submitted to BSE SME and compiled across fundamental research platforms like Screener.in and Trendlyne, the ₹56-crore public issue follows a structured timeline designed for institutional and retail participation.
| Event / Catalyst Milestone | Exact Calendar Date |
|---|---|
| IPO Opening Date | September 11, 2026 |
| IPO Review Published by Dilip Davda | September 11, 2026 |
| Allotment Finalization | Pending official confirmation |
| Listing on BSE SME Exchange | Pending official confirmation |
| Financial Metric / Parameter | Details / Value |
|---|---|
| Total Issue Size | ₹56 Crore |
| Listing Exchange | BSE SME |
| Target Segment | SME Public Offering |
Grey Market Premium (GMP) Tracking
According to early updates tracked across IPOWatch and Chittorgarh on Wednesday, September 16, 2026, the Grey Market Premium (GMP) for Injecto Polymers IPO has not yet actively started in the unlisted grey market. Market trackers note that participants are awaiting further subscription milestones and institutional bidding updates before quoting concrete Kostak or Subject to Sauda rates. GMP figures remain entirely unofficial street estimates subject to high volatility.
Valuation & Peer Comparison Context
To evaluate whether Injecto Polymers offers compelling value at its ₹56-crore issue size, analysts cross-reference fundamental metrics against comparable specialty polymer and manufacturing peers listed on Indian exchanges.
| Company / Peer Name | P/E Ratio | Issue Size / Market Cap | Key Note |
|---|---|---|---|
| Injecto Polymers IPO | Pending Review | ₹56 Crore | BSE SME Segment |
| Peer Comparison Data | Pending | Various | Peer comparison data pending verification |
Peer valuation data sourced from Screener.in and Trendlyne
Bull vs Bear Investment Framework
Growth Catalysts (Bull Case)
- Specialized positioning in polymer manufacturing catering to growing industrial applications.
- Capital infusion via the ₹56-crore issue provides necessary expansion liquidity.
- Favorable sentiment surrounding niche SME public offerings on the BSE platform.
Downside Risks (Bear Case)
- SME stocks carry higher liquidity risk and wider bid-ask spreads compared to mainboard equities.
- Absence of established grey market premium (GMP) indicates initial speculative caution.
- Raw material price volatility can impact operating margins in the polymer sector.
Analytical Investment Verdict
Suitable For: HNI and informed risk-tolerant investors
Risk Level: High — SME segment volatility and unverified initial grey market momentum warrant careful review of RHP financials.
Key Watch Point: Subscription velocity and final basis of allotment announcements.
Investor Frequently Asked Questions (FAQ)
What is the total issue size of Injecto Polymers IPO?
Injecto Polymers is mobilizing ₹56 crore through its SME public offering listed on the BSE SME platform.
Has the grey market premium (GMP) started for Injecto Polymers IPO?
According to trackers like IPOWatch and Chittorgarh, the GMP has not yet commenced in the grey market as of mid-September 2026.
When did the Injecto Polymers IPO open for bidding?
The SME IPO officially opened for public bidding on Friday, September 11, 2026.
SEBI Compliance & Statutory Disclaimer
The information and analysis presented on IPO Bulletin (ipobulletin.com) are for informational and educational purposes only and do not constitute financial, investment, or legal advice. Securities market investments are subject to market risks; please read all offer documents (DRHP/RHP) thoroughly before committing capital. Grey Market Premium (GMP) figures are unofficial, unregulated street estimates. Always consult a SEBI-registered investment advisor before making financial decisions.
Sources cross-checked for this article: Chittorgarh, Moneycontrol, IPOWatch, BSE India filings, Screener.in.